Dialog Solutions (now Clarivate) (@DialogSols) header
Dialog Solutions (now Clarivate) (@DialogSols) profile picture

Dialog Solutions is now Clarivate. Follow us at @clarivatehealth to stay up to date.

Global
Joined October 2019
Want to learn how our solutions can advance #innovation and accelerate #patient outcomes? Follow us at @ClarivateHealth.
1
73
No-one can change the world alone. Learn how we use #intelligence to ensure #patients are at the heart of everything you do at clarivate.com
1
43
Dialog Solutions (now Clarivate) retweeted
We're here at @DrugInfoAssn Annual Meeting! Visit Booth #113 to learn how to drive #clinicaldevelopment, #regulatory success, and #pharmacovigilance or meet us at Fenway Park tonight for Boston Red Sox games to network. Book a meeting here: ow.ly/jkSX50OXbRc
1
5
228
We’re moving to @ClarivateHealth >> follow us to learn about our #biopharma, #medtech and #RWD solutions.
1
34
Dialog Solutions (now Clarivate) retweeted
We look forward to meeting with #healthcare professionals, patients, and #regulators at the @DrugInfoAssn #DIA2023 Annual Meeting. Visit Booth no.113 to discover how our #intelligence solutions can empower a healthier tomorrow. Learn more, here: diaglobal.org/Flagship/DIA-2…
1
164
Dialog Solutions (now Clarivate) retweeted
NEWS >> Henry Levy named President of our #LifeSciences & #Healthcare market segment, effective May 1. Read the press release to learn how he will accelerate growth in this newly created role: clarivate.com/news/clarivate…
3
3
834
Enable your pharmacovigilance experts to keep focus on what matters most – patient safety – by using pharmacovigilance tools and a process that simplifies the repetitive and tedious literature review. Find out more: clarivate.com/products/bioph…
1
Dialog Solutions, Part of Clarivate worked with @GSK to create a proof of concept for our AI PV literature monitoring tool DialogML 🤖💊. Read all about it and the great results it demonstrated 📊: https://nitter.cf/t.co/rWPjP0L0Rs #drugsafety #pharmacovigilance @ClarivateHealth
4
6
We get asked a lot of questions about #systematic #review #literature #searching. In our blog we've answered the questions we get asked most often - take a read and let us know if there's anything else you'd like answered! https://nitter.cf/t.co/c04ShB3DbK #systematicreview #literature
1
3
Publicly Available Content, a database of #fulltext #openaccess journals, is now available 🆓📚 on Dialog. Add it to your Dialog searches for an additional source of #greyliterature. Learn more in our blog: https://nitter.cf/t.co/N1sKfG5Z8I
2
This 18-step checklist can help you ensure your approach to drug safety literature monitoring is in-line with industry best practice https://nitter.cf/t.co/5a6xv41FSP #QPPV #Pharmacovigilance
1
Dialog alerts deliver relevant literature for drug safety aggregate reports, including #PSUR, #PBRER and #DSUR. Find out more about how Dialog alerts can streamline your pharmacovigilance literature monitoring: lnkd.in/gF5vHUnJ
1
How can the Drug Safety Literature Screening processes be made more efficient without making it less thorough? Click on the link below to learn more: youtu.be/lHhUbi9vWlU #pharmacovigilance
1
How to improve Drug Safety Literature Screening Compliance? Pls find the link to the video here: lnkd.in/g2kksAhR
1
Dialog Solutions (now Clarivate) retweeted
Have a question🙋🏾‍♀️about the #Embase or #MEDLINE #databases 📚 that you're too scared to ask? Our blog might be able to help you out... https://nitter.cf/t.co/EfAP3NVDdZ
1
1
Have a question🙋🏾‍♀️about the #Embase or #MEDLINE #databases 📚 that you're too scared to ask? Our blog might be able to help you out... https://nitter.cf/t.co/EfAP3NVDdZ
1
1
Is your Patent search sophisticated enough? At Dialog solutions, we are helping organizations around the world transform how they deliver their state-of-the-art and patent research, more in the link https://nitter.cf/t.co/NU9uyAbGqa
1
3
Do you know four ways to deliver efficient EU MDR literature reviews? Take a look at our guide if you want to check you're doing everything you need to: https://nitter.cf/t.co/fAxluENsnI #EUMDR #CER #clinical #evaluation #report
2